// App-Quantinova.ai

PB0910 : Comparison of standard vs low dose of direct oral anticoagulants for the secondary prophylaxis of venous thromboembolism in patients affected by hematologic malignancies

Researchers

Presenter

  • A. Serrao

Principal Investigators

  • E. Baldacci

  • C. Santoro

  • A. Chistolini

Medical Centers

  • Sapienza University of Rome, Rome, Italy, Rome, Italy

  • Hematology, University Hospital Policlinico Umberto I, Rome, Rome, Lazio, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Hematological malignancies

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved